| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | The Fund is a long/short investment fund principally investing in listed entities, commodities, futures and options in Australia and internationally. The Fund is not a market neutral fund and accordingly may switch between net long positions and net short positions. The Fund may use short sales and derivatives. Gearing may be used to enhance returns and the Fund may be geared in excess of 100% of the Fund's Net Asset Value. There is a limit to net exposure of 150%. |
| Manager Comments | At month-end, the fund had a net exposure of 36.7% and a gross exposure of 275.4%. The fund held 114 positions (57 long and 57 short) that were diversified across multiple investment themes. Top contributors were a short position in Estia Health and long positions in Altium and Shriro. Biggest detractors were long positions in McMillan Shakespeare, CSL, and Northern Star. Click below to read the latest Fund's Monthly Report. |
| More Information |
